CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleRevenue is $595.95M, above the global median of $520.53M
- FinancialsAltman Z-Score 4.71: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.10%Above 5Y avg (2.31%)
Annual Rate
GBP 0.19Paid semi-annual
Payout Ratio
41.1%Sustainable
Payback Period
32.3 yr
Last Ex-Dividend
May 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
669.18MGBP911.96M · vs all stocks (USD)
Trailing P/E
14.33xRevenue (TTM)
437.30MGBP595.95M · vs all stocks (USD)
Profit Margin
10.77%Beta
0.3550xvs all stocks
52-Week Change
-12.10%vs all stocks
Market Capitalization
669.18MGBP911.96M · vs all stocks (USD)
Enterprise Value
643.18MGBP876.52M · vs all stocks (USD)
Trailing P/E
14.33xForward P/E
11.70xPrice to Sales (TTM)
1.53xPrice to Book (MRQ)
1.98xEnterprise to Revenue
1.47xEnterprise to EBITDA
8.74xProfit Margin
10.77%Operating Margin
14.34%Return on Assets (TTM)
8.57%Return on Equity (TTM)
14.08%Revenue (TTM)
437.30MGBP595.95M · vs all stocks (USD)
Revenue per Share (TTM)
3.92GBPUpdated Aug 21, 2026Quarterly Revenue Growth
5.10%Gross Profit (TTM)
177.30MGBP241.62M · vs all stocks (USD)
EBITDA (TTM)
74.60MGBP101.66M · vs all stocks (USD)
Net Income (TTM)
47.10MGBP64.19M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-7.60%Operating Cash Flow (TTM)
51.00MGBP69.50M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
20.13MGBP27.43M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1871GBPUpdated Aug 21, 2026Trailing Annual Dividend Yield
3.10%vs all stocks
5-Year Average Dividend Yield
2.31%vs all stocks
Payout Ratio
41.15%Minority Interest (Equity)
7.60MGBPFY2026 · Jan 31, 2026Revenue
437.30MGBPFY2026 · Jan 31, 2026Cost of Goods Sold
260.00MGBPFY2026 · Jan 31, 2026Gross Profit
177.30MGBPFY2026 · Jan 31, 2026Operating Income
61.60MGBP83.95M · vs all stocks (USD)
Pre-tax Income
62.60MGBPFY2026 · Jan 31, 2026Income Tax Expense
15.90MGBPFY2026 · Jan 31, 2026Net Income
46.70MGBPFY2026 · Jan 31, 2026EBIT
63.30MGBPFY2026 · Jan 31, 2026EBITDA (Income Statement)
74.60MGBPFY2026 · Jan 31, 2026Selling, General & Administrative
115.70MGBPFY2026 · Jan 31, 2026Non-operating Interest Income
1.60MGBPFY2026 · Jan 31, 2026Non-operating Interest Expense
700.00KGBPFY2026 · Jan 31, 2026Minority Interests (P&L)
-400.00KGBPFY2026 · Jan 31, 2026Preferred Stock Dividends
0.00GBPFY2026 · Jan 31, 2026Operating Cash Flow
63.80MGBPFY2026 · Jan 31, 2026Free Cash Flow
36.10MGBPFY2026 · Jan 31, 2026Cash & Cash Equivalents (End of Period)
61.40MGBPFY2026 · Jan 31, 2026Starting Profit (CF Statement)
62.60MGBPFY2026 · Jan 31, 2026Stock-based Compensation
2.50MGBPFY2026 · Jan 31, 2026Other Non-cash Items
-1.50MGBPFY2026 · Jan 31, 2026Change in Accounts Receivable (CF)
-2.10MGBPFY2026 · Jan 31, 2026Change in Other Assets/Liabilities
2.30MGBPFY2026 · Jan 31, 2026Capital Expenditures
-27.70MGBPFY2026 · Jan 31, 2026Net Acquisitions
-18.80MGBPFY2026 · Jan 31, 2026Purchase of Investments
-107.10MGBPFY2026 · Jan 31, 2026Sale of Investments
129.60MGBPFY2026 · Jan 31, 2026Net Investing Cash Flow
-24.00MGBPFY2026 · Jan 31, 2026Long-term Debt Payments
-11.60MGBPFY2026 · Jan 31, 2026Net Short-term Debt Issuance
38.40MGBPFY2026 · Jan 31, 2026Common Stock Repurchase
-5.00MGBPFY2026 · Jan 31, 2026Common Dividends Paid
-19.20MGBPFY2026 · Jan 31, 2026Net Financing Cash Flow
3.30MGBPFY2026 · Jan 31, 2026Shares Outstanding
110.98MSharesUpdated Aug 21, 2026Float Shares
87.81MSharesUpdated Aug 21, 2026% Held by Insiders
9.28%vs all stocks
% Held by Institutions
43.11%vs all stocks
Total Cash (MRQ)
81.60MGBP111.20M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7350GBPUpdated Aug 21, 2026Total Debt (MRQ)
48.00MGBP65.41M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1389xCurrent Ratio (MRQ)
1.67xBook Value per Share (MRQ)
3.05GBPUpdated Aug 21, 2026Total Assets
514.20MGBP700.75M · vs all stocks (USD)
Total Current Assets
196.30MGBPFY2026 · Jan 31, 2026Total Liabilities
168.60MGBPFY2026 · Jan 31, 2026Total Non-current Assets
317.90MGBPFY2026 · Jan 31, 2026Total Non-current Liabilities
50.90MGBPFY2026 · Jan 31, 2026Total Current Liabilities
117.70MGBPFY2026 · Jan 31, 2026Cash & Cash Equivalents
61.40MGBPFY2026 · Jan 31, 2026Other Short-term Investments
20.40MGBPFY2026 · Jan 31, 2026Accounts Receivable
77.30MGBPFY2026 · Jan 31, 2026Inventory
31.70MGBPFY2026 · Jan 31, 2026Accounts Payable
33.80MGBPFY2026 · Jan 31, 2026Short-term Debt
41.80MGBPFY2026 · Jan 31, 2026Long-term Debt
6.20MGBPFY2026 · Jan 31, 2026Other Non-current Liabilities
2.00MGBPFY2026 · Jan 31, 2026Common Stock (Book)
4.70MGBPFY2026 · Jan 31, 2026Retained Earnings
328.10MGBPFY2026 · Jan 31, 2026Total Shareholders' Equity
345.60MGBP470.98M · vs all stocks (USD)
52-Week Low
589.00GBXUpdated Aug 21, 202652-Week High
715.32GBXUpdated Aug 21, 202652-Week Change
-12.10%vs all stocks
Beta
0.3550xvs all stocks
50-Day MA
632.30GBXUpdated Aug 21, 2026200-Day MA
639.10GBXUpdated Aug 21, 2026Avg 10-Day Volume
133.63KSharesUpdated Aug 21, 2026Avg 30-Day Volume
193.92KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.4200GBPUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.71: safe zoneNotable
Altman Z-Score: 4.71
High earnings qualityNotable
Earnings Quality Score: 0.91
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Revenue is $595.95M, above the global median of $520.53MNotable
Revenue (USD): 595,948,067Global Median: 520,528,949.311
Levered free cash flow is $27.43M, above the global median of $16.24MNotable
Levered free cash flow (USD): 27,426,148.75Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Forest Cabin Cosmetics Group Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Pn Gadgil Jewellers Ltd.
Tier 1ProductionBrand-Compounding ConsumerInterfaceAttention
Primax Electronics Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
John B. Sanfilippo & Son, Inc.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Jiangxi Huangshanghuang Group Food Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Cosmecca Korea Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowSenseMaking
Namchow Food Group Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Vulcabras S.A.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Bata India Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Ultrajaya Milk Industry & Trading Company Tbk
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Companies that share active interpretations — structural patterns currently present in both stocks.
Youngy Health Co., Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value
Hanyu Group Joint Stock Limited
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value
Chengdu Shengbang Seals Co. Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value